Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it
“That means of the $141 million they spent on this drug in 2022, $133 million of it was wasted”
By News on the Net -- Wall Street Apes—— Bio and Archives--March 21, 2025
News in Brief—News Headlines | Comments | Back To Full Article
This is the worst one yet. Pharmaceutical companies skyrocket the price of prescriptions to Medicare because taxpayers are paying for it
— Wall Street Apes (@WallStreetApes)March 21, 2025
- Drug Tetrabenazine, Medicare pays $2,600 per prescription
- Regular price $75
- Medicare is paying 34X THE PRICE PER PRESCRIPTION
-… pic.twitter.com/vRd3cwmBcB
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy